Putkonen M - Search Results

1

Single-dose pegfilgrastim is comparable to daily filgrastim in mobilizing peripheral blood stem cells: a case-matched study in patients with lymphoproliferative malignancies.

Putkonen M, Rauhala A, Pelliniemi TT, Remes K. Putkonen M, et al. Ann Hematol. 2009 Jul;88(7):673-80. doi: 10.1007/s00277-008-0675-5. Epub 2009 Jan 13. Ann Hematol. 2009. PMID: 19139894 Free article.

2

Cost analysis of a randomized stem cell mobilization study in multiple myeloma.

Varmavuo V, Silvennoinen R, Anttila P, Säily M, Sankelo M, Putkonen M, Ahonen J, Mahlamäki E, Mäntymaa P, Savolainen ER, Remes K, Jantunen E. Varmavuo V, et al. Among authors: putkonen m. Ann Hematol. 2016 Oct;95(10):1653-9. doi: 10.1007/s00277-016-2772-1. Epub 2016 Aug 3. Ann Hematol. 2016. PMID: 27485453 Clinical Trial.

3

RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group.

Luoma S, Anttila P, Säily M, Lundan T, Heiskanen J, Siitonen T, Kakko S, Putkonen M, Ollikainen H, Terävä V, Sankelo M, Partanen A, Launonen K, Räsänen A, Sikiö A, Suominen M, Bazia P, Kananen K, Lievonen J, Selander T, Pelliniemi TT, Ilveskero S, Huotari V, Mäntymaa P, Tienhaara A, Jantunen E, Silvennoinen R. Luoma S, et al. Among authors: putkonen m. Ann Hematol. 2019 Dec;98(12):2781-2792. doi: 10.1007/s00277-019-03815-7. Epub 2019 Oct 31. Ann Hematol. 2019. PMID: 31673775 Free PMC article. Clinical Trial.

4

Sepsis, low platelet nadir at mobilization and previous IFN use predict stem cell mobilization failure in patients with multiple myeloma.

Putkonen M, Rauhala A, Pelliniemi TT, Remes K. Putkonen M, et al. Cytotherapy. 2007;9(6):548-54. doi: 10.1080/14653240701508429. Cytotherapy. 2007. PMID: 17882719

5

Depth of response assessed by quantitative ASO-PCR predicts the outcome after stem cell transplantation in multiple myeloma.

Putkonen M, Kairisto V, Juvonen V, Pelliniemi TT, Rauhala A, Itälä-Remes M, Remes K. Putkonen M, et al. Eur J Haematol. 2010 Nov;85(5):416-23. doi: 10.1111/j.1600-0609.2010.01510.x. Eur J Haematol. 2010. PMID: 20722702

6

Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison.

Valtola J, Silvennoinen R, Ropponen A, Siitonen T, Säily M, Sankelo M, Terävä V, Putkonen M, Kuittinen T, Pelkonen J, Mäntymaa P, Remes K, Varmavuo V, Jantunen E. Valtola J, et al. Among authors: putkonen m. Transfusion. 2016 Jun;56(6):1394-401. doi: 10.1111/trf.13574. Epub 2016 Apr 4. Transfusion. 2016. PMID: 27041692 Clinical Trial.

7

Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma.

Jantunen E, Putkonen M, Nousiainen T, Pelliniemi TT, Mahlamäki E, Remes K. Jantunen E, et al. Among authors: putkonen m. Bone Marrow Transplant. 2003 Mar;31(5):347-51. doi: 10.1038/sj.bmt.1703840. Bone Marrow Transplant. 2003. PMID: 12634725

8

Double versus single autotransplantation in multiple myeloma; a single center experience of 100 patients.

Putkonen M, Rauhala A, Itälä M, Kauppila M, Pelliniemi TT, Remes K. Putkonen M, et al. Haematologica. 2005 Apr;90(4):562-3. Haematologica. 2005. PMID: 15820960

9

[Directions for allogenic stem cell transplants and how they reflect on the operation and results of the transfer center in Turku].

Remes K, Luoma S, Salmi TT, Tarja-Terttu P, Itälä M, Kauppila M, Nikoskelainen J, Putkonen M, Kairisto V, Rajamäki A, Tienhaara A, Pyrhönen S, Rauhala A. Remes K, et al. Among authors: putkonen m. Duodecim. 2005;121(19):2085-97. Duodecim. 2005. PMID: 16300297 Review. Finnish. No abstract available.

10

Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.

Jantunen E, Wiklund T, Juvonen E, Putkonen M, Lehtinen T, Kuittinen O, Franssila K, Söderström KO, Leppä S, Elonen E, Remes K, Nousiainen T. Jantunen E, et al. Among authors: putkonen m. Bone Marrow Transplant. 2004 Feb;33(4):405-10. doi: 10.1038/sj.bmt.1704367. Bone Marrow Transplant. 2004. PMID: 14676776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters